University of California at Davis Medical Center
Welcome,         Profile    Billing    Logout  
 10 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
McDonald, Craig M
HOPE-3, NCT05126758: A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Active, not recruiting
3
104
US
Deramiocel (CAP-1002), Cardiosphere-Derived Cells (CDCs), Placebo
Capricor Inc.
Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn, Nervous System Diseases
12/25
12/27
ENVISION, NCT05881408 / 2020-002372-13: A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Recruiting
3
148
Europe, Japan, US, RoW
delandistrogene moxeparvovec, SRP-9001, delandistrogene moxeparvovec-rokl, ELEVIDYS, placebo
Sarepta Therapeutics, Inc., Hoffmann-La Roche
Duchenne Muscular Dystrophy
05/27
06/28
HOPE-2-OLE, NCT04428476: Open-label Extension of the HOPE-2 Trial

Active, not recruiting
2
13
US
Deramiocel (CAP-1002), Allogeneic Cardiosphere-Derived Cells
Capricor Inc.
Duchenne Muscular Dystrophy
02/22
03/26
MOMENTUM, NCT04004065 / 2019-000601-77: Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Checkmark From MOMENTUM trial for DMD
May 2021 - May 2021: From MOMENTUM trial for DMD
Checkmark Interim data from the MOMENTUM study
Dec 2020 - Dec 2020: Interim data from the MOMENTUM study
Checkmark Data from MOMENTUM trial for Duchenne muscular dystrophy
More
Active, not recruiting
2
62
Europe, Canada, US
Vesleteplirsen, SRP-5051
Sarepta Therapeutics, Inc.
Duchenne Muscular Dystrophy
10/23
01/29
NCT06138639: A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

Recruiting
1/2
43
Canada, US
SGT-003
Solid Biosciences Inc.
Duchenne Muscular Dystrophy
05/27
05/31
NCT03863119: Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

Available
N/A
Canada, US, RoW
Vamorolone
Santhera Pharmaceuticals
Duchenne Muscular Dystrophy
 
 
NCT04475926: A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Recruiting
N/A
241
Europe, Canada, US, RoW
Sarepta Therapeutics, Inc.
Limb-girdle Muscular Dystrophy
04/30
04/30
Chan, Andrew T
PACE-NODES, NCT05613023: A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT

Recruiting
3
1128
Europe, RoW
SBRT, SABR
Institute of Cancer Research, United Kingdom, Prostate Cancer UK
Prostate Cancer
06/28
06/30
NCT02584244: Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Recruiting
1/2
66
US
LUM015, LUM 2.6 Imaging Device
Lumicell, Inc., National Cancer Institute (NCI)
Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer, Gastric Cancer
12/25
04/26
NCT05056896: ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Active, not recruiting
1
161
US
Aspirin, acetylsalicylic acid (ASA), Salicylic Acid Acetate, Placebo
Massachusetts General Hospital, National Cancer Institute (NCI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)
Colorectal Cancer
11/24
12/25
ASPIRED, NCT02394769: ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Active, not recruiting
N/A
180
US
Aspirin, 2-Acetylsalicylic Acid, ASA, Placebo for Aspirin
Massachusetts General Hospital, National Cancer Institute (NCI)
Colorectal Cancer
04/19
07/29
NCT04331509: COVID-19 Symptom Tracker

Recruiting
N/A
10000000
Europe, US
No Intervention
King's College London, Zoe Global Limited, Massachusetts General Hospital, Harvard School of Public Health (HSPH), Stanford University
COVID-19
03/23
03/23
NCT04407585: Testing the Accuracy of a Digital Test to Diagnose Covid-19

Recruiting
N/A
1000000
Europe
Covid-19 swab PCR test
King's College London, Zoe Global Limited, Department of Health, United Kingdom
Covid-19
05/23
05/23
Southard, Jeffrey
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Active, not recruiting
N/A
1948
Canada, US
ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
09/34
Diaz-Vigil, Daniel
STOP360AG, NCT05548283: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Recruiting
4
730
Canada, US
Beta-lactam antibiotic, β-lactam, Aminoglycoside, AG
Chris Goss, University of Washington, Medical University of South Carolina, Cystic Fibrosis Foundation
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
11/26
11/26
OUTREACH, NCT05285410: Observational Study Comparing Home to Office Spirometry

Completed
N/A
116
US
Chris Goss, University of Washington, University of Arkansas, Harvard University, Cystic Fibrosis Foundation
Cystic Fibrosis
12/23
12/23
Lin, Chia-Yi
ENVISION, NCT05881408 / 2020-002372-13: A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Recruiting
3
148
Europe, Japan, US, RoW
delandistrogene moxeparvovec, SRP-9001, delandistrogene moxeparvovec-rokl, ELEVIDYS, placebo
Sarepta Therapeutics, Inc., Hoffmann-La Roche
Duchenne Muscular Dystrophy
05/27
06/28
NCT06103045: The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function of Stroke at Acute Stage.

Recruiting
N/A
30
RoW
unilateral and bilateral mirror therapy
National Taiwan University Hospital Hsin-Chu Branch
Stroke, Acute
02/25
02/25

Download Options